BioCentury
ARTICLE | Company News

Vestar Inc. deal

March 21, 1994 8:00 AM UTC

Vestar Inc. (VSTR), San Dimas, Calif. 4Q ended Dec. 31: Sales of VSTR's AmBisome liposomal antifungal were $8.1 million vs. $7.9 million in the 1992 quarter. The net loss was $4.4 million (32 cents ...